Of note, enrichment of the BRAF V600E mutation in cutaneous metastatic disease has also been documented for other types of cancer (lung cancer, papillary thyroid carcinoma), which only rarely affect the skin (10, 11). This evidence concerns the gene BRAF and lung carcinoma.